AAAAAA

   
Results: 1-9 |
Results: 9
Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma
Authors: McCune, SL Gockerman, JP Rizzieri, DA
Citation: Sl. Mccune et al., Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma, J AM MED A, 286(10), 2001, pp. 1149-1152
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
Authors: Laughlin, MJ Barker, J Bambach, B Koc, ON Rizzieri, DA Wagner, JE Gerson, SL Lazarus, HM Cairo, M Stevens, CE Rubinstein, P Kurtzberg, J
Citation: Mj. Laughlin et al., Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors., N ENG J MED, 344(24), 2001, pp. 1815-1822
Nuclear factor-kappa B is constitutively activated in primitive human acute myelogenous leukemia cells
Authors: Guzman, ML Neering, SJ Upchurch, D Grimes, B Howard, DS Rizzieri, DA Luger, SM Jordan, CT
Citation: Ml. Guzman et al., Nuclear factor-kappa B is constitutively activated in primitive human acute myelogenous leukemia cells, BLOOD, 98(8), 2001, pp. 2301-2307
Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen
Authors: Rizzieri, DA Long, GD Vredenburgh, JJ Gasparetto, C Morris, A Stenzel, TT Davis, P Chao, NJ
Citation: Da. Rizzieri et al., Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen, BLOOD, 98(12), 2001, pp. 3486-3488
Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells
Authors: Guzman, ML Upchurch, D Grimes, B Howard, DS Rizzieri, DA Luger, SM Phillips, GL Jordan, CT
Citation: Ml. Guzman et al., Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells, BLOOD, 97(7), 2001, pp. 2177-2179
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells
Authors: Jordan, CT Upchurch, D Szilvassy, SJ Guzman, ML Howard, DS Pettigrew, AL Meyerrose, T Rossi, R Grimes, B Rizzieri, DA Luger, SM Phillips, GL
Citation: Ct. Jordan et al., The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells, LEUKEMIA, 14(10), 2000, pp. 1777-1784
Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy
Authors: Elconin, JH Roberts, KB Rizzieri, DA Vermont, C Clough, RW Kim, C Dodge, RK Prosnitz, LR
Citation: Jh. Elconin et al., Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy, INT J RAD O, 48(4), 2000, pp. 1097-1105
Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer
Authors: Howard, DS Rizzieri, DA Grimes, B Upchurch, D Phillips, GL Stewart, AK Yannelli, JR Jordan, CT
Citation: Ds. Howard et al., Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer, LEUKEMIA, 13(10), 1999, pp. 1608-1616
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support
Authors: Rizzieri, DA Vredenburgh, JJ Jones, R Ross, M Shpall, EJ Hussein, A Broadwater, G Berry, D Petros, WP Gilbert, C Affronti, ML Coniglio, D Rubin, P Elkordy, M Long, GD Chao, NJ Peters, WP
Citation: Da. Rizzieri et al., Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support, J CL ONCOL, 17(10), 1999, pp. 3064-3074
Risultati: 1-9 |